Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Share News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Reckitt Q3 sales top estimates on coronavirus demand for cleaning products

Tue, 20th Oct 2020 07:08

* Reckitt raises full-year sales outlook

* Products including Dettol, Lysol in demand

* Shares rise 2% in early trade
(Adds CEO comments, share reaction)

By Martinne Geller

LONDON, Oct 20 (Reuters) - Reckitt Benckiser reported
on Tuesday a much bigger-than-expected rise in third-quarter
sales and raised its full-year outlook, as the coronavirus
pandemic lifts demand for its cleaning products.

The British maker of Dettol and Lysol said its plan to
rejuvenate sales following years of difficulties may be achieved
a year earlier than expected.

"While there is still more work to do, I'm pleased to say
that RB today is in much better shape than it was a year ago,"
Chief Executive Laxman Narasimhan, who has been in the role for
a year, told reporters.

Reckitt shares were up 2% at 0705 GMT in London. They had
gained 17.5% this year by Monday's close.

The company said sales on a like-for-like basis, excluding
items such as foreign exchange fluctuations, rose 13.3%.
Analysts on average expected a 9.5% increase, according to a
consensus provided by the company.

Quarterly net revenue was 3.51 billion pounds ($4.5
billion), up from 3.21 billion pounds a year earlier.

The company raised its full-year net revenue outlook, saying
it expects a low double-digit rise, up from a previous forecast
of high single-digit growth.

Like-for-like sales rose 19.5% in the company's hygiene
business in the third quarter, 12.6% in its health business,
which includes Durex condoms and Mucinex cold medicine, and 4.1%
in its nutrition business, which includes Enfamil baby formula.

The COVID-19 pandemic has relieved pressure on a business
that has struggled against intense competition in the health and
hygiene sectors for several years.

Reckitt is preparing to sell some of its personal care
brands, including Veet hair removal cream and Clearasil acne
cream, Reuters reported last month.
($1 = 0.7739 pounds)
(Reporting by Martinne Geller; editing by Jason Neely/Keith
Weir/Susan Fenton)

More News
21 Jul 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Jul 2020 13:32

Monday broker round-up

(Sharecast News) - British American Tobacco: Jefferies downgrades to hold with a target price of 3,000.0p.

Read more
20 Jul 2020 11:23

Deutsche Bank raises target price on Reckitt Benckiser

(Sharecast News) - Analysts at Deutsche Bank upped their target price on consumer goods company Reckitt Benckiser from 7,400.0p to 8,400.0p on Monday, highlighting the group's "enduring fame".

Read more
20 Jul 2020 09:38

UK BROKER RATINGS SUMMARY: Barclays Downgrades Standard Life Aberdeen

UK BROKER RATINGS SUMMARY: Barclays Downgrades Standard Life Aberdeen

Read more
16 Jul 2020 22:34

Brazilian waste management firm finds cost-cutting users in pandemic

By Tatiana BautzerSAO PAULO, July 16 (Reuters) - A month-old Brazilian company's machines that use bacteria to break down organic waste has found users among domestic upscale supermarket Natural da Terra, units of Reckitt Benckiser and Siemens AG ...

Read more
10 Jul 2020 09:43

UK BROKER RATINGS SUMMARY: Investec Ups Barclays; HSBC Cuts RSA

UK BROKER RATINGS SUMMARY: Investec Ups Barclays; HSBC Cuts RSA

Read more
9 Jul 2020 13:51

Thursday broker round-up

(Sharecast News) - Hargreaves Lansdown: Berenberg reiterates hold with a target price of 1,830.0p.

Read more
9 Jul 2020 09:36

UK BROKER RATINGS SUMMARY: RBC Downgrades Compass To Underperform

UK BROKER RATINGS SUMMARY: RBC Downgrades Compass To Underperform

Read more
6 Jul 2020 09:15

UK BROKER RATINGS SUMMARY: Credit Suisse Downgrades BHP To Neutral

UK BROKER RATINGS SUMMARY: Credit Suisse Downgrades BHP To Neutral

Read more
30 Jun 2020 21:48

UPDATE 2-Former Indivior CEO pleads guilty in U.S. in opioid addiction treatment probe

(Adds comment from defense lawyer and Indivior)By Nate RaymondJune 30 (Reuters) - Shaun Thaxter, the former chief executive of drugmaker Indivior Plc, pleaded guilty on Tuesday to a criminal charge arising out of a U.S. Justice Department investig...

Read more
30 Jun 2020 21:48

UPDATE 1-Former Indivior CEO pleads guilty in U.S. in opioid addiction treatment probe

(Adds further details on case, background on investigation)By Nate RaymondJune 30 (Reuters) - Shaun Thaxter, the former chief executive of drugmaker Indivior Plc, pleaded guilty on Tuesday to a criminal charge arising out of a U.S. Justice Departm...

Read more
30 Jun 2020 14:20

Tuesday broker round-up

(Sharecast News) - Paragon: Canaccord upgrades to buy with a target price of 454.0p.

Read more
30 Jun 2020 09:31

UK BROKER RATINGS SUMMARY: Exane BNP Downgrades RELX To Underperform

UK BROKER RATINGS SUMMARY: Exane BNP Downgrades RELX To Underperform

Read more
29 Jun 2020 13:45

Monday broker round-up

(Sharecast News) - Balfour Beatty: Jefferies downgrades to hold with a target price of 260.0p.

Read more
29 Jun 2020 10:29

Indivior Names Promotes Finance Head Crossley To CEO, Thaxter Departs

Indivior Names Promotes Finance Head Crossley To CEO, Thaxter Departs

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.